Literature DB >> 69670

Pilot studies on recombinant cold-adapted live type A and B influenza virus vaccines.

F M Davenport, A V Hennessy, H F Maassab, E Minuse, L C Clark, G D Abrams, J R Mitchell.   

Abstract

Recombinant live attenuated type A and B influenza virus vaccines derived from standardized cold-adapted parent strains were given singly and in combination to volunteers. The vaccine viruses were well tolerated, functioned as good antigens, and failed to spread to intimate household contacts. Thirty-nine isolates that were recovered after a single passage in humans appeared genetically stable. The results of histopathologic studies in ferrets encourage development of an animal model for attenuation of the virus.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 69670     DOI: 10.1093/infdis/136.1.17

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  Evaluation of a cold-adapted influenza B/Texas/84 reassortant virus (CRB-87) vaccine in young children.

Authors:  E L Anderson; F K Newman; H F Maassab; R B Belshe
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

Review 2.  Pathogenicity of influenza virus.

Authors:  C Sweet; H Smith
Journal:  Microbiol Rev       Date:  1980-06

3.  Characterization of the temperature sensitive phenotype of the A/Ann Arbor/6/60 cold-adapted virus and its recombinants.

Authors:  B R Murphy; H F Maassab; F T Wood; R M Chanock
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

4.  Intrinsic interference between influenza A and B viruses.

Authors:  A Mikheeva; Y Z Ghendon
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

5.  Evaluation of A/Alaska/6/77 (H3N2) cold-adapted recombinant viruses derived from A/Ann Arbor/6/60 cold-adapted donor virus in adult seronegative volunteers.

Authors:  B R Murphy; R M Chanock; M L Clements; W C Anthony; A J Sear; L A Cisneros; M B Rennels; E H Miller; R E Black; M M Levine; R F Betts; R G Douglas; H F Maassab; N J Cox; A P Kendal
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

6.  Molecular and biological changes in the cold-adapted "master strain" A/AA/6/60 (H2N2) influenza virus.

Authors:  M L Herlocher; H F Maassab; R G Webster
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

7.  Dose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus.

Authors:  M L Clements; S O'Donnell; M M Levine; R M Chanock; B R Murphy
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

8.  Secretory and systemic immunological response in children infected with live attenuated influenza A virus vaccines.

Authors:  B R Murphy; D L Nelson; P F Wright; E L Tierney; M A Phelan; R M Chanock
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

9.  Different virulence of influenza A virus strains and susceptibility to pneumococcal otitis media in chinchillas.

Authors:  G S Giebink; P F Wright
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

10.  Cold-adapted variants of influenza A virus: evaluation in adult seronegative volunteers of A/Scotland/840/74 and A/Victoria/3/75 cold-adapted recombinants derived from the cold-adapted A/Ann Arbor/6/60 strain.

Authors:  B R Murphy; H P Holley; E J Berquist; M M Levine; S B Spring; H F Maassab; A P Kendal; R M Chanock
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.